Madeline Friedman-DeLuca

Madeline Friedman-DeLuca

Auto-generated profile, based on publicly available information

Madeline Friedman-DeLuca

Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
BSBenson Chellakkan Selvanesan
Benson Chellakkan Selvanesan
DCDinesh Chandra
Dinesh Chandra
WQWilber Quispe-Tintaya
Wilber Quispe-Tintaya
AJArthee Jahangir
Arthee Jahangir
APAnkur Patel
Ankur Patel
Claudia GravekampClaudia Gravekamp
Claudia Gravekamp
Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease. Tumors are poorly immunogenic and immunosuppressive, preventing T cell activation in the tumor microenvironment. Here, we present a microbial-based immunotherapeutic treatment for selective delivery of an immunogenic tetanus toxoid protein (TT 856-1313 ) into PDAC tumor cells by attenuated Listeria monocytogenes . This treatment reactivated preexisting TT-specific memory T cells to kill infected tumor cells in mice. Treatment of KrasG12D,p53R172H, Pdx1-Cre (KPC) mice with Listeria -TT resulted in TT accumulation inside tumor cells, attraction of TT-specific memory CD4 T cells to the tumor microenvironment, and production of perforin and granzyme B in tumors. Low doses of gemcitabine (GEM) increased immune effects of Listeria -TT, turning immunologically cold into hot tumors in mice. In vivo depletion of T cells from Listeria -TT + GEM–treated mice demonstrated a CD4 T cell–mediated reduction in tumor burden. CD4 T cells from TT-vaccinated mice were able to kill TT-expressing Panc-02 tumor cells in vitro. In addition, peritumoral lymph node–like structures were observed in close contact with pancreatic tumors in KPC mice treated with Listeria -TT or Listeria -TT + GEM. These structures displayed CD4 and CD8 T cells producing perforin and granzyme B. Whereas CD4 T cells efficiently infiltrated the KPC tumors, CD8 T cells did not. Listeria -TT + GEM treatment of KPC mice with advanced PDAC reduced tumor burden by 80% and metastases by 87% after treatment and increased survival by 40% compared to nontreated mice. These results suggest that Listeria -delivered recall antigens could be an alternative to neoantigen-mediated cancer immunotherapy.

8 August 2022 in Pancreatology
Verified
Journal Article
Closed access
ASAva Siegel
Ava Siegel
MFMadeline Friedman
Madeline Friedman
DFDan Feldman
Dan Feldman
KKKumar Krishnan
Kumar Krishnan
BCBrenna Casey
Brenna Casey
DCDaniel C. Chung
Daniel C. Chung

15 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MFMadeline Friedman-DeLuca
Madeline Friedman-DeLuca
GKGeorge S Karagiannis
George S Karagiannis
CDCamille L Duran
Camille L Duran
SSSuryansh Shukla
Suryansh Shukla
JLJiufeng Li
Jiufeng Li
DEDavid Entenberg
David Entenberg
Metastasis is the leading cause of breast cancer death, and tumor cells must migrate and invade to metastasize. Breast cancer cells that express the pro-metastatic actin regulatory protein MenaINV have an enhanced ability to migrate and intravasate within the primary tumor and extravasate at secondary sites. Though chemotherapy improves patient survival, treatment with paclitaxel leads to upregulation of MenaINV and an increase in metastasis in mice. MenaINV expression can be induced in breast cancer cells through cooperative NF-κB/ Notch1 signaling with macrophages, which are often increased in tumors in response to chemotherapy. MenaINV-expressing cells are also resistant to paclitaxel, raising the question of whether paclitaxel increases MenaINV by de novo induction or by selectively killing non-MenaINV-expressing cells. We hypothesized that paclitaxel causes de novo MenaINV induction by increasing macrophage-tumor cell NF-κB/ Notch1 signaling. Understanding this pro-metastatic effect of chemotherapy is crucial to refining treatment strategies. In this study, we demonstrate that paclitaxel increases MenaINV expression by de novo induction. Mechanistically, paclitaxel induces MenaINV by repolarizing tumor-associated macrophages towards a pro-inflammatory phenotype. These pro-inflammatory macrophages then participate in enhanced NF-κB/ Notch1 signaling with tumor cells, which leads to MenaINV induction in the tumor cells. These results lay the groundwork for novel microenvironment-based therapies to alleviate the pro-metastatic effects of chemotherapy in breast cancer.

23 May 2025 in AJPM Focus
Verified
Journal Article
Open access
BBBrett I. Bell
Brett I. Bell
SHSarah Hill
Sarah Hill
JOJustin Olivera
Justin Olivera
VFValerie Fong
Valerie Fong
MSMichelle Schumacher
Michelle Schumacher
CSCara Stephenson-Hunter
Cara Stephenson-Hunter
COVID-19 exacerbated inequities, impacting Black and Latinx communities in the Bronx, New York. COVID vaccination rates in the Bronx were initially lower, likely owing to vaccine confidence and hesitancy. Despite improved vaccination rates, persistent vaccine nonconfidence poses health equity challenges. The authors explored the factors contributing to vaccine nonconfidence among community members and healthcare providers. The authors conducted a mixed-methods study with community members and healthcare providers. Thematic analysis was utilized for the conversations and focus groups, and surveys were analyzed quantitatively. Analysis of conversations and focus groups with 43 Bronx community members identified 6 themes: mistrust, autonomy, structural racism, misinformation and disinformation, faith and religion, and social responsibility. Misinformation, disinformation, mistrust, and patient–provider relationship issues significantly influenced vaccine nonconfidence. Structural racism contributed to limited access and racial prejudice. Religious beliefs influenced decision making, highlighting faith-based organizations' importance. Surveys of 48 providers revealed concerns about side effects, rapid vaccine rollout, misinformation, and community influence. This study provides insights into the factors contributing to vaccine nonconfidence in the Bronx. Addressing these issues requires community-centered approaches and interventions that build trust, improve access, and provide accurate information. The authors propose integrating these findings into a novel curriculum to train Bronx medical students to work toward these goals.